| Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators IF Zattoni, LC Delabio, J de Paula Dutra, DH Kita, G Scheiffer, ... European Journal of Medicinal Chemistry 237, 114346, 2022 | 51 | 2022 |
| Structural and molecular characterization of lopinavir and ivermectin as breast cancer resistance protein (BCRP/ABCG2) inhibitors J de Paula Dutra, G Scheiffer, T Kronenberger, LJC Gomes, I Zanzarini, ... EXCLI journal 22, 1155, 2023 | 4 | 2023 |
| Magnolol derivatives as specific and noncytotoxic inhibitors of breast cancer resistance protein (BCRP/ABCG2) I da Silva Zanzarini, DH Kita, G Scheiffer, KK Dos Santos, ... Bioorganic Chemistry 146, 107283, 2024 | 1 | 2024 |
| In silico approaches supporting drug repurposing for Leishmaniasis: a scoping review G Scheiffer, KZA Domingues, D Gorski, A de Fátima Cobre, REL Lazo, ... EXCLI Journal 23, 1117-1169, 2024 | | 2024 |